Glucagon-Like Peptide-1 Receptor Agonist and Basal Insulin Combination Treatment for the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis

Study Questions:

What is the effect of combination treatment with a glucagon-like peptide-1 (GLP-1) agonist and basal insulin on glycemic control, hypoglycemia, and weight gain in patients with type 2 diabetes?